Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
59.90
-0.59 (-0.98%)
At close: Oct 30, 2026, 4:00 PM EDT
59.75
-0.15 (-0.25%)
After-hours: Oct 30, 2026, 7:30 PM EDT
Arrowhead Pharmaceuticals Market Cap
Arrowhead Pharmaceuticals has a market cap or net worth of $8.46 billion as of October 30, 2026. It is the 2,398th most valuable company in the world and the 853rd biggest in the United States. Its market cap has increased by 51.89% in one year.
Market Cap
8.46B
Enterprise Value
8.24B
1-Year Change
51.89%
Global Rank
Country Rank
#853 United States
Category
ChartMarket Cap Chart
Since January 15, 2004, Arrowhead Pharmaceuticals's market cap has increased from $300.00K to $8.46B, an increase of 2,820,280.86%. That is a compound annual growth rate of 56.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 8.46B | -6.16% |
| Dec 31, 2025 | 9.02B | 285.42% |
| Dec 31, 2024 | 2.34B | -28.84% |
| Dec 29, 2023 | 3.29B | -23.54% |
| Dec 30, 2022 | 4.30B | -37.84% |
| Dec 31, 2021 | 6.92B | -11.95% |
| Dec 31, 2020 | 7.86B | 29.67% |
| Dec 31, 2019 | 6.06B | 451.13% |
| Dec 31, 2018 | 1.10B | 299.42% |
| Dec 29, 2017 | 275.20M | 154.58% |
| Dec 30, 2016 | 108.10M | -70.48% |
| Dec 31, 2015 | 366.20M | -9.27% |
| Dec 31, 2014 | 403.60M | -3.88% |
| Dec 31, 2013 | 419.90M | 1,153.43% |
| Dec 31, 2012 | 33.50M | -24.04% |
| Dec 30, 2011 | 44.10M | -31.42% |
| Dec 31, 2010 | 64.30M | 93.09% |
| Dec 31, 2009 | 33.30M | -15.70% |
| Dec 31, 2008 | 39.50M | -72.93% |
| Dec 31, 2007 | 145.90M | -2.60% |
| Dec 29, 2006 | 149.80M | 25.99% |
| Dec 30, 2005 | 118.90M | 101.87% |
| Dec 31, 2004 | 58.90M | 19,533.33% |
| Jan 15, 2004 | 300.00K | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Caris Life Sciences | 9.70B |
| Twist Bioscience | 9.58B |
| Protagonist Therapeutics | 9.37B |
| Spyre Therapeutics | 9.02B |
| ImmunityBio | 8.79B |
| Corcept Therapeutics | 8.77B |
| Cytokinetics | 8.76B |
| TG Therapeutics | 8.68B |